Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 7101852

Composition and method for treatment and prevention of restenosis

The Board of Regents of the University of Texas System · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094758

Apoptotic compounds

The Board of Regents of the University of Texas System · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094873

Polypeptide that interacts with heat shock proteins

The Board of Regents of the University of Texas System · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7078182

TAO protein kinase polypeptides and methods of use therefor

The Board of Regents of the University of Texas System · Granted Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7071318

Methods and compositions for stabilizing microtubules and intermediate filaments in striat

The Board of Regents of the University of Texas System · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7070957

STARS—a muscle-specific actin-binding protein

The Board of Regents of the University of Texas System · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7067111

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific dise

The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7067633

Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in

The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7067256

Ribozyme mediated inactivation of the androgen receptor

The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7067109

Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7067254

Diagnosis and treatment of inflammation and hyperactive immune conditions

The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7060689

Methods and compositions for delivery and retention of active agents to lymph nodes

The Board of Regents of the University of Texas System · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7056509

Antibody methods for selectively inhibiting VEGF

The Board of Regents of the University of Texas System · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7041784

Apoptotic compounds

The Board of Regents of the University of Texas System · Granted Tue May 09 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7037583

Functionalized zirconium oxide particles

The Board of Regents of the University of Texas System · Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7033750

Recombinant P53 adenovirus methods and compositions

The Board of Regents of the University of Texas System · Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7029696

Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II)

The Board of Regents of the University of Texas System · Granted Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7022484

Methods for treating neuropathological states and neurogenic inflammatory states and metho

The Board of Regents of the University of Texas System · Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7022720

Synthetic diazonamides as novel anti-mitotic agents

The Board of Regents of the University of Texas System · Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7008633

Local regional chemotherapy and radiotherapy using in situ hydrogel

The Board of Regents of the University of Texas System · Granted Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7005512

Methods and compositions for stabilizing microtubules and intermediate filaments in striat

The Board of Regents of the University of Texas System · Granted Tue Feb 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7005424

Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells

The Board of Regents of the University of Texas System · Granted Tue Feb 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6998117

Cancer treatment with retroviral vectors comprising wild-type p53

The Board of Regents of the University of Texas System · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6995188

S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino)

The Board of Regents of the University of Texas System · Granted Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)